Ignite Creation Date:
2024-05-06 @ 1:46 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04123470
Status:
COMPLETED
Last Update Posted:
2023-08-29
First Post:
2019-10-09
Brief Title:
A Phase III Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Sponsor:
Lokon Pharma AB
Organization:
Lokon Pharma AB
Organization Data
Organization:
Lokon Pharma AB
Class:
INDUSTRY
Study ID:
LOKON003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lokon Pharma AB
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Precision Oncology LLC | UNKNOWN |